Most bought healthcare stocks in Q1 2019
See which Healthcare stocks institutional investors increased the most in Q1 2019, measured as net growth in reported share positions from Q4 2018 into Q1 2019. Notable additions at the top of this list include TAKEDA PHARMACEUTIC-SP ADR (TAK), BRISTOL-MYERS SQUIBB CO (BMY), BOSTON SCIENTIFIC CORP (BSX), GILEAD SCIENCES INC (GILD). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 10,852,990 | $228.90M | 1 | 1 | 0 | 0 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | 8,829,421 | $200.15M | 3 | 4 | 3 | 1 | 11 |
| BSX | BOSTON SCIENTIFIC CORP | 5,264,022 | $218.63M | 3 | 0 | 3 | 0 | 6 |
| GILD | GILEAD SCIENCES INC | 4,904,016 | $408.45M | 2 | 6 | 0 | 1 | 9 |
| PFE | PFIZER INC | 4,743,186 | $181.10M | 3 | 2 | 8 | 0 | 14 |
| ABBV | ABBVIE INC | 4,310,226 | $340.70M | 2 | 4 | 3 | 2 | 10 |
| ELAN | ELANCO ANIMAL HEALTH INC | 3,928,752 | $126.00M | 2 | 0 | 0 | 0 | 2 |
| EXEL | EXELIXIS INC | 3,667,366 | $111.73M | 2 | 1 | 0 | 0 | 3 |
| CVS | CVS HEALTH CORP | 3,663,609 | -$235.27M | 1 | 5 | 3 | 1 | 10 |
| CNC | CENTENE CORP | 3,440,173 | $96.93M | 1 | 3 | 1 | 0 | 5 |
| SAVA | CASSAVA SCIENCES INC | 2,280,073 | $2.94M | 2 | 0 | 0 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 2,161,897 | $13.60M | 0 | 1 | 0 | 0 | 1 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 1,822,332 | $194.99M | 2 | 0 | 1 | 0 | 3 |
| ALGN | ALIGN TECHNOLOGY INC | 1,793,586 | $948.74M | 3 | 5 | 1 | 0 | 9 |
| EDIT | EDITAS MEDICINE INC | 1,634,345 | $47.15M | 0 | 2 | 0 | 0 | 3 |
| MYGN | MYRIAD GENETICS INC | 1,511,931 | $55.73M | 0 | 1 | 0 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | 1,511,546 | $369.35M | 1 | 7 | 6 | 0 | 18 |
| GOSS | GOSSAMER BIO INC | 1,267,171 | $26.11M | 1 | 0 | 0 | 0 | 1 |
| MCRB | SERES THERAPEUTICS INC | 1,265,534 | $20.27M | 0 | 2 | 0 | 0 | 2 |
| OMI | OWENS & MINOR INC | 1,202,462 | $4.93M | 2 | 0 | 0 | 0 | 2 |
| ELV | ELEVANCE HEALTH INC | 1,179,304 | $547.72M | 2 | 4 | 4 | 0 | 11 |
| CERS | CERUS CORP | 1,162,679 | $15.06M | 2 | 1 | 0 | 0 | 3 |
| INCY | INCYTE CORP | 969,146 | $182.06M | 2 | 3 | 0 | 0 | 5 |
| HROW | HARROW INC | 967,806 | $4.82M | 1 | 0 | 0 | 0 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 951,246 | $40.36M | 0 | 1 | 0 | 1 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | 924,064 | $8.82M | 2 | 0 | 0 | 0 | 2 |
| LAB | STANDARD BIOTOOLS INC | 914,200 | $17.95M | 0 | 1 | 0 | 0 | 1 |
| BIIB | BIOGEN INC | 910,381 | $126.27M | 2 | 3 | 0 | 1 | 6 |
| XRAY | DENTSPLY SIRONA INC | 902,732 | $138.65M | 1 | 3 | 1 | 1 | 5 |
| ALKS | ALKERMES PLC | 856,760 | $36.81M | 1 | 1 | 0 | 0 | 2 |
| ZTS | ZOETIS INC | 852,229 | $322.75M | 1 | 3 | 1 | 0 | 6 |
| PRGO | Perrigo Company PLC | 839,600 | $57.70M | 0 | 2 | 1 | 0 | 3 |
| VRTX | VERTEX PHARMACEUTICALS INC | 764,536 | $219.69M | 1 | 1 | 0 | 0 | 2 |
| CMRX | CHIMERIX INC | 762,515 | $1.34M | 0 | 1 | 0 | 0 | 1 |
| PCRX | PACIRA BIOSCIENCES INC | 708,300 | $25.20M | 0 | 1 | 0 | 0 | 1 |
| APYX | APYX MEDICAL CORP | 676,107 | $4.27M | 1 | 0 | 0 | 0 | 1 |
| GMAB | GENMAB A/S -SP ADR | 658,895 | $11.54M | 0 | 1 | 0 | 0 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | 646,514 | $334.47M | 1 | 2 | 8 | 0 | 14 |
| MCK | MCKESSON CORP | 642,785 | $143.72M | 1 | 2 | 3 | 1 | 6 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 634,393 | $162.83M | 1 | 2 | 0 | 0 | 3 |
| MGNX | MACROGENICS INC | 627,623 | $12.32M | 0 | 1 | 0 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | 626,502 | $96.49M | 1 | 1 | 1 | 0 | 3 |
| BHC | BAUSCH HEALTH COS INC | 625,522 | $180.99M | 2 | 1 | 1 | 0 | 6 |
| DHR | DANAHER CORP | 621,609 | $504.96M | 1 | 4 | 3 | 0 | 10 |
| A | AGILENT TECHNOLOGIES INC | 578,528 | $129.64M | 1 | 2 | 1 | 0 | 5 |
| CLDX | CELLDEX THERAPEUTICS INC | 545,106 | $2.68M | 1 | 0 | 0 | 0 | 1 |
| PINC | PREMIER INC-CLASS A | 495,836 | $10.24M | 1 | 2 | 0 | 0 | 3 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 492,547 | $1.37M | 0 | 1 | 0 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | 442,300 | $10.81M | 0 | 1 | 1 | 0 | 4 |
| ILMN | ILLUMINA INC | 438,319 | $153.66M | 1 | 4 | 0 | 0 | 5 |
Frequently asked questions about Most bought healthcare stocks in Q1 2019
What are the most bought Healthcare stocks in Q1 2019?
The most bought healthcare stocks in Q1 2019 are those with the largest increase in reported share counts across institutional investors compared to Q4 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2019?
Among filers in this sector, net additions were largest in companies such as TAKEDA PHARMACEUTIC-SP ADR (TAK), BRISTOL-MYERS SQUIBB CO (BMY), BOSTON SCIENTIFIC CORP (BSX), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2018).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.